BiomX Inc.
PHGE
$0.601
-$0.01-1.64%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 54.77% | 34.13% | 16.07% | 1.30% | -9.49% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 40.25% | 26.03% | 21.27% | -1.78% | -6.87% |
| Operating Income | -40.25% | -26.03% | -21.27% | 1.78% | 6.87% |
| Income Before Tax | 32.25% | 67.20% | -3.38% | -40.33% | 7.45% |
| Income Tax Expenses | -43.48% | -81.97% | -68.85% | -64.52% | -64.62% |
| Earnings from Continuing Operations | 32.26% | 67.23% | -3.20% | -40.08% | 7.59% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 32.26% | 67.23% | -3.20% | -40.08% | 7.59% |
| EBIT | -40.25% | -26.03% | -21.27% | 1.78% | 6.87% |
| EBITDA | -37.88% | -26.24% | -23.91% | -1.69% | 2.38% |
| EPS Basic | 64.33% | 68.47% | 50.88% | 35.01% | 42.75% |
| Normalized Basic EPS | 60.80% | 58.54% | 37.79% | 29.79% | 42.67% |
| EPS Diluted | 14.87% | 28.44% | 16.02% | 34.99% | 42.73% |
| Normalized Diluted EPS | 58.47% | 56.58% | 36.09% | 29.79% | 42.67% |
| Average Basic Shares Outstanding | 134.52% | 106.07% | 78.31% | 93.11% | 71.67% |
| Average Diluted Shares Outstanding | 172.68% | 150.95% | 132.64% | 93.11% | 71.67% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |